Abstract:As chemotherapy is generally used in the clinical treatment of cancer, the problem of multidrug resistance (MDR) of tumors against the chemotherapeutic agents becomes more and more serious. It has been the major cause for the failure of the chemotherapy. We detected the expressions of beta-catenin and tumor drug resistance related proteins, MRP2, P-gp, and Bcl-2, in esophageal squamous cell carcinoma (ESCC) to explore their function and correlation in the occurrence and development of MDR in ESCC.We used the tissue microarray technique, immunohistochemistry, and image analysis methods to detect the expressions of MRP2, P-gp, beta-catenin, and Bcl-2 proteins and analyze their relationships with clinical data in a ESCC tissue microarray consisting of 582 specimens of ESCC, 294 specimens of normal mucosa, 92 specimens of basal cell hyperplasia, and 87 specimens of dysplasia adjacent to cancer tissue.The integral optical density (IOD) of MRP2 and Bcl-2, which was 195.7 +/- 175.9 x 10(3)) and 90.5 +/- 112.5 x 10(3)), respectively, was significantly higher in ESCC than in normal mucosa, which was 104.8 +/- 86.1 x103) and 25.2 +/- 46.6 x 10(3)), respectively (P < 0.01). The IOD of P-gp and beta-catenin, which was 57.7 +/- 75.5 x 10(3)) and 32.0 +/- 47.0 x 10(3)) respectively, was significantly lower in ESCC than in normal mucosa, which was 114.8 +/- 106.6 x 10(3)) and 46.1 +/- 35.7 x 10(3)), respectively (P < 0.01). According to the following order, well differentiated moderately differentiated poorly differentiated, the IOD of MRP2 increased in ESCC (P < 0.01). The IOD of beta-catenin was higher in poorly differentiated ESCC than in well or moderately differentiated ESCC (P < 0.01). The IOD of Bcl-2 was lower in well differentiated ESCC than in poorly and moderately differentiated ESCC (P < 0.01). The IOD of beta-catenin and Bcl-2 was higher in the ESCC of specimens with infiltration depths that were in membrane mucosa than those in the muscular layer or serous coat (P < 0.01). The IOD of Bcl-2 was significantly higher in cases with lymph node metastasis than in cases without (P < 0.01). Positive correlations which were respectively between the expressions of P-gp and MRP2, the expressions of P-gp and Bcl-2 were found (r = 0.288 and r = 0.253, respectively, P < 0.01).MRP2, P-gp, and Bcl-2 may be taken as prognostic factors for MDR of ESCC. beta-catenin may play an important role in carcinogenesis and progression of ESCC.

Cytoplasmic HDPR1 is Involved in Regional Lymph Node Metastasis and Tumor Development Via Beta-Catenin Accumulation in Esophageal Squamous Cell Carcinoma

Diagnostic and Prognostic Value of HSPD1 in Oesophageal Cancer

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Expression of E-Cadherin and Β-Catenin in Human Esophageal Squamous Cell Carcinoma: Relationships with Prognosis

HDAC2 Regulates Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Esophageal Squamous Cell Carcinoma EC9706 Cells

Abnormally High HIP1 Expression is Associated with Metastatic Behaviors and Poor Prognosis in ESCC

PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma

Expression and significance of tumor drug resistance related proteins and β-catenin in esophageal squamous cell carcinoma

β-catenin expression and prognosis in human esophageal squamous cell carcinoma

Prognostic Relevance Ofβ-Cateninexpression in T2-3N0M0 Esophageal Squamous Cell Carcinoma

Overexpression of PRR11 Promotes Tumorigenic Capability and is Associated with Progression in Esophageal Squamous Cell Carcinoma

Programmed Death-Ligand 1 is Prognostic Factor in Esophageal Squamous Cell Carcinoma and is Associated with Epidermal Growth Factor Receptor

Correlation Of Cd133, E-Cadherin, And Beta-Catenin With Metastasis And Prognosis In Esophageal Squamous Cell Carcinoma

High Expression of Heat Shock Protein Family D Member 1 Predicts Poor Prognosis of Esophageal Cancer

Independent Prognostic Role of PD-L1expression in Patients with Esophageal Squamous Cell Carcinoma.

Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

Prognostic relevance of Centromere protein H expression in esophageal carcinoma

Epidermal Growth Factor Receptor and B7-H3 Expression in Esophageal Squamous Tissues Correlate to Patient Prognosis.

High Expression of EphA1 in Esophageal Squamous Cell Carcinoma is Associated with Lymph Node Metastasis and Advanced Disease

Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma.

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy